Next, a significant relationship was found between a higher PARP expression and various clinicopathological risk factors, such as tumour size, tumour differentiation, lymph node metastasis, distant metastasis, TNM stage, and lymphovascular invasion. The gene discussed is PARP1; the disease is neoplasm.